Kozhnosys developed by the CanScan prototype is being utilized in an observational study to collect and analyze volatile markers in the exhaled breath of cancer (GI, Cervical, Colorectal, head and neck) patients.
- Conditions
- Health Condition 1: R978- Other abnormal tumor markers
- Registration Number
- CTRI/2024/03/063799
- Lead Sponsor
- Kozhnosys Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria for GI, Cervical, Colorectal, head, and neck Cancer
1. Willing to fill out the informed consent form
2. Female in the age group 20 to 80 years Women with newly diagnosed cancer (GI, Cervical, Colorectal, head, and neck) with/without common medical conditions like Hypertension, Hyperlipidaemia, Hypothyroidism, Arthritis, Asthma, GERD, Diabetes, PCOD, Vitamin deficiencies, etc. -20 evaluable subjects (4 patients each with above-mentioned cancer)
3. Confirmed cases of GI, Cervical, Colorectal, head, and neck cancer but not exposed to any previous treatment cycle/surgery.
4. Cases confirmed through endoscopy, PAP smear, Colonoscopy, MRI/CT, Ultrasonography or blood tests.
Exclusion Criteria for GI, Cervical, Colorectal, head, and neck cancer
1. The age group is below 20 years.
2. Any known illness within 2 weeks from breath collection.
3. Already undergoing cancer treatment.
4. Undergone surgery for cancer tumor removal.
5. Undergoing chemo/radiation therapy for cancer treatment.
6. Positive, but no GI, Cervical, Colorectal, head, and neck cancer on the later investigation (Positive Sonography but negative biopsy report).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VOC (Volatile organic compounds) profile in GI, colorectal, cervical, Head & neck cancers.Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Detection of volatile markers of biomarkers in GI, Colorectal, Cervical, Head, and Neck cancers using Canscan prototype. <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 4 weeks